MRC Epidemiology Unit

 

When nonplatinum is the answer: the role of trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer.

Colombo N

Future oncology (London, England). Oct 2017

(DOI : 10.2217/fon-2017-0319)

---